Evidence map›Paper›PMID 36725082›Full record

ArticleBMJ open respiratory research2023

Central lung gene expression associates with myofibroblast features in idiopathic pulmonary fibrosis.

Yong Huang, Rob Guzy, Shwu-Fan Ma, Catherine A Bonham, Jonathan Jou, Jefree J Schulte, John S Kim, Andrew J Barros, Milena S Espindola, Aliya N Husain and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open respiratory research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Yong Huang *Division of Pulmonary & Critical Care Medicine, University of Virginia, Charlottesville, Virginia, USA.
Rob Guzy *Section of Pulmonary & Critical Care Medicine, University of Chicago, Chicago, Illinois, USA.
Shwu-Fan Ma *Division of Pulmonary & Critical Care Medicine, University of Virginia, Charlottesville, Virginia, USA.
Catherine A BonhamDivision of Pulmonary & Critical Care Medicine, University of Virginia, Charlottesville, Virginia, USA.ORCID 0000-0001-9132-4083
Jonathan JouDepartment of Surgery, University of Illinois, Peoria, Illinois, USA.
Jefree J SchulteDepartment of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin, USA.
John S KimDivision of Pulmonary & Critical Care Medicine, University of Virginia, Charlottesville, Virginia, USA.ORCID 0000-0002-8887-150X
Andrew J BarrosDivision of Pulmonary & Critical Care Medicine, University of Virginia, Charlottesville, Virginia, USA.
Milena S EspindolaDivision of Pulmonary & Critical Care Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Aliya N HusainDepartment of Pathology, University of Chicago, Chicago, Illinois, USA.
Cory M HogaboamDivision of Pulmonary & Critical Care Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Anne I SperlingDivision of Pulmonary & Critical Care Medicine, University of Virginia, Charlottesville, Virginia, USA.
Imre NothDivision of Pulmonary & Critical Care Medicine, University of Virginia, Charlottesville, Virginia, USA IN2C@hscmail.mcc.virginia.edu.
University of Virginia · USCedars-Sinai Medical Center · USUniversity of Chicago · USPeoria campus of the University of Illinois System · USUniversity of Wisconsin–Madison · US

Funding

Role of Surfactant Proteins in Mediating Noninfectious Inflammatory and FibroproP01HL108793 · NHLBI · DUKE UNIVERSITY · PI JIANG, DIANHUA · 2012 to 2022
$21.3M
Architectural structure and regulation of TOLLIP in IPFR01HL130796 · NHLBI · UNIVERSITY OF VIRGINIA · PI NOTH, IMRE · 2016 to 2019
$3.1M
IRF4+ respiratory dendritic cells in type 2 inflammatory responsesR01AI125644 · NIAID · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN, SPERLING, ANNE I. · 2017 to 2021
$2.1M
1/2 Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases studyUG3HL145266 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MARTINEZ, FERNANDO J, NOTH, IMRE · 2019 to 2019
$977k
Role of polyunsaturated fatty acids in pulmonary fibrosisK23HL150301 · NHLBI · UNIVERSITY OF VIRGINIA · PI KIM, JOHN S · 2021 to 2025
$858k
Mechanism of Fibroblast Growth Factor 2-Mediated Alveolar Epithelial RepairK08HL125910 · NHLBI · UNIVERSITY OF CHICAGO · PI GUZY, ROBERT DAVID · 2017 to 2021
$820k
T cells in idiopathic pulmonary fibrosisK23HL143135 · NHLBI · UNIVERSITY OF VIRGINIA · PI BONHAM, CATHERINE ANN · 2018 to 2021
$662k
NHLBI NIH HHS K08 HL125910NHLBI NIH HHS K23 HL143135NHLBI NIH HHS K23 HL150301NHLBI NIH HHS P01 HL108793NHLBI NIH HHS R01 HL130796NHLBI NIH HHS UG3 HL145266NIAID NIH HHS R01 AI125644
6 · The paper itself

Abstract

rationaleContribution of central lung tissues to pathogenesis of idiopathic pulmonary fibrosis (IPF) remains unknown.

objectiveTo ascertain the relationship between cell types of IPF-central and IPF-peripheral lung explants using RNA sequencing (RNA-seq) transcriptome.

methodsBiopsies of paired IPF-central and IPF-peripheral along with non-IPF lungs were selected by reviewing H&E data. Criteria for differentially expressed genes (DEG) were set at false discovery rate <5% and fold change >2. Computational cell composition deconvolution was performed. Signature scores were computed for each cell type.

findingsComparison of central IPF versus non-IPF identified 1723 DEG (1522 upregulated and 201 downregulated). Sixty-two per cent (938/1522) of the mutually upregulated genes in central IPF genes were also upregulated in peripheral IPF versus non-IPF. Moreover, 85 IPF central-associated genes (CAG) were upregulated in central IPF versus both peripheral IPF and central non-IPF. IPF single-cell RNA-seq analysis revealed the highest CAG signature score in myofibroblasts and significantly correlated with a previously published activated fibroblasts signature (r=0.88, p=1.6×10

interpretationGene expression in central IPF lung regions demonstrates active myofibroblast features that contributes to disease progression. Further elucidation of pathological transcriptomic state of cells in the central regions of the IPF lung that are relatively spared from morphological rearrangements may provide insights into molecular changes in the IPF progression.

Indexed as

Idiopathic Pulmonary FibrosisMyofibroblastsFibroblastsGene ExpressionHumansLunginterstitial fibrosis

Identifiers

PMID36725082
PMCPMC9896241
OpenAlexW4318815856

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.